Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. ACN
9. COHR
10. META

Go back to Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
(NASDAQ: NKTX) Delayed: 2.88 +0.05 (1.77%)
Previous Close $2.83    52 Week High $ 
Open $2.87    52 Week Low $ 
Day High $2.91    P/E N/A 
Day Low $2.80    EPS $ 
Volume 385,792